Needham says the firm uncovered DocuSign (DOCU) is testing new pricing and packaging for its Esignature professional tier. This A/B testing does not seem to cover its IAM solution. Needham spoke to management yesterday who did confirm the company is testing pricing and packaging but acknowledged no decisions on these changes have been made at this time. The firm notes that the new pricing test for the Professional tier represents a 50% increase from the existing plan but does increase the number of envelopes sent annually from 100 to unlimited while also adding lightweight AI functionality for contract analysis. Needham believes the potential impact of this change is impossible to calculate as it is missing significant data for this exercise, but it would expect any pricing exercise will lead to some growth tailwinds in 2027 and 2028. The firm has a Hold rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU:
- DocuSign: Early-Stage Pricing Experiments Create Uncertain Upside, Justifying a Hold Rating
- DocuSign Appoints Brian Roberts as Independent Board Director
- DocuSign announces partnership with Anthropic
- Midday Fly By: Trump ups worldwide tariff to 15%, Gilead buying Arcellx
- Alphabet, Nvidia upgraded: Wall Street’s top analyst calls
